Nurse Anesthetist - CR in Painesville, OH Accepting Medicare

9 Nurse Anesthetist - CR nurses found. Showing 1 - 9

Sara J Miller, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 7757 Auburn Rd Ste 15, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Patricia Deming, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Karen E Turner, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 40 W Erie St, Painesville, OH 44077 Phone: 440-205-5467

Tina Marie Gruly, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 7757 Auburn Rd Ste 15, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Mrs. Jaime M Polt, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Ste 203, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Mrs. Holly Marie Hengstenberger, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Emily Kristen Chakraborty, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 7757 Auburn Rd Ste 15, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Scott M Schulte, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 40 West Erie St Ste 203, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

Stacey Marie Jansen, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832    Fax: 440-354-7420

News Archive

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapies addressing high-unmet medical needs, today announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone with Hapten Pharmaceuticals, LLC.

Social networks can spread misunderstandings about proper use of antibiotics

Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).

BAI and Novartis determine whether investigational drugs can prevent symptoms of Alzheimer's

Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.

Swine Flu - getting drugs to the market more rapidly

The pharmaceutical industry has been up in arms this year. Giants such as Pfizer, GSK and AstraZeneca are looking for deals in the downturn whilst competing against increasing generic competition as some of the best selling medicines are coming off patent. In addition to the sectors ever-changing landscape companies are under tremendous pressure from governments to combat the Swine flu pandemic that has gripped the world.

Exemestane has negative effect on postmenopausal women's bone health

Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.

Read more Medical News

› Verified 3 days ago